Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Phase 1 cancer clinical trials are more beneficial for participants than they used to be, says Naoko Takebe, MD, PhD.
Advocates push for increased federal cancer research funding among list of essential cancer priorities
A new study identifies a potential approach to prevent mental fog, a common treatment side effect.
Black patients with ovarian cancer were less likely than their white counterparts to be treated according to NCCN guidelines.
The collaboration will help advance understanding of the biological basis of pediatric cancers and accelerate cures globally.
Tests prevented relapse and limited graft-vs.-host disease (GVHD) in laboratory models of leukemia and multiple myeloma.
Damon Runyon researchers outfitted T cells with a mutated cytokine receptor, enabling them to attack melanoma and pancreatic cancer.
Study results support the need for research into the value of monitoring these breast cancer patients with brain imaging tests.
Gavin Ha explains his research on liquid biopsies—blood samples with traces of DNA that provide molecular details about cancer.
Joining First Lady Jill Biden, R&B icon Mary J. Blige spoke about racial disparities in cancer prevention and treatment.
University of California San Francisco hosted First Lady Jill Biden to speak about the Cancer Moonshot and breast cancer research.
The patient-driven Metastatic Prostate Cancer Research Project releases its first report.
The CU Cancer Center was one of the clinical trial sites for Optune, which creates electrical fields that stop cancer cells from dividing.
Black women were more likely to benefit than white women if treated at an earlier disease stage but less likely at a later stage.
Tumor immune microenvironments may provide clues to future therapies, say UCSF-led researchers.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.